Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Prehypertension: should we be treating with pharmacologic therapy?Brent M Egan, Shawna D Nesbitt, Stevo JuliusAmerican Journal of Hypertension|August 2, 2005
Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY studyShawna D Nesbitt, Stevo Julius, David Leonard, et al.Journal of Hypertension|November 27, 2013
In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertensionStevo Julius, Brent M Egan, Niko A Kaciroti, et al.Circulation|April 25, 2019
Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic OriginsKeith C Ferdinand, Fabrice Balavoine, Bruno Besse, et al.Ethnicity & Disease|March 9, 2004
Overweight as a risk factor in children: a focus on ethnicityShawna D Nesbitt, Modele O Ashaye, Nicolas Stettler, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|June 14, 2008
An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY)Setareh A Williams, Eric L Michelson, Valerie A Cain, et al.The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
Reversible sympathetic overactivity in hypertensive patients with primary aldosteronismAndrew C Kontak, Zhongyun Wang, Debbie Arbique, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|June 9, 2011
A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazideMatthew R Weir, Willa A Hsueh, Shawna D Nesbitt, et al.The New England Journal of Medicine|March 16, 2006
Feasibility of treating prehypertension with an angiotensin-receptor blockerStevo Julius, Shawna D Nesbitt, Brent M Egan, et al.Journal of Hypertension|March 19, 2005
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudyMichael H Olsen, Eigil Fossum, Aud Høieggen, et al.Pageof 3